04:21 PM EDT, 09/20/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) increased its settlement commitment to resolve existing and potential claims associated with ovarian cancer from cosmetic talc litigation by $1.75 billion to $8 billion.

The proposed settlement is part of a voluntary prepackaged chapter 11 bankruptcy plan filed by the Red River Talc unit in US Bankruptcy Court for the Southern District of Texas, Johnson & Johnson ( JNJ ) said Friday in a statement.

About 83% of the current claimants and the future claims representative supported the plan, Johnson & Johnson ( JNJ ) said.

"The overwhelming support for the plan demonstrates the company's extensive, good-faith efforts to resolve this litigation for the benefit of all stakeholders," Erik Haas, worldwide vice president of litigation at Johnson & Johnson ( JNJ ), said in the statement. ""This plan is fair and equitable to all parties and, therefore, should be expeditiously confirmed by the Bankruptcy Court."

"The company reiterates that none of the talc-related claims against it have merit," according to the statement.